Skip to main content

Day: March 5, 2021

CGG : annonce ses résultats du quatrième trimestre et de l’année 2020

 CGG annonce ses résultats du quatrième trimestreet de l’année 2020Solide performance opérationnelle au T4 2020Génération de Cash-Flow Net positive en 2021 soutenue par une reprise progressive de l’activitéPARIS, France – 5 mars 2021 – CGG (ISIN: FR0013181864), leader mondial dans les Géosciences, annonce ses résultats audités du T4 et de l’année 2020.Sophie Zurquiyah, Directeur Général de CGG, a déclaré :« Nous avons terminé cette année 2020 particulièrement difficile, marquée par l’effondrement de notre industrie au deuxième et troisième trimestre, avec une solide performance opérationnelle au quatrième trimestre. En 2020, nous avons poursuivi le développement de nos technologies de géoscience de haut de gamme pour le développement et la production de réservoirs, le déploiement de nos programmes multi-clients dans les principaux bassins...

Continue reading

Corbion full year 2020 results

Corbion reported net sales of € 986.5 million in 2020. Organic net sales growth was 5.6% forthe year. Adjusted EBITDA in 2020 increased organically by 13.4% to € 158.8 million. The company proposes to distribute a regular cash dividend of € 0.56 per share.Olivier Rigaud, CEO, commented: “2020 has been a remarkable year. Following the presentation of our strategy, Advance 2025, in March, most of the world went into lockdown and our priorities became: safeguarding the health of our colleagues, securing supplies, and ensuring that our customers would continue to get their deliveries on time and in full. This resulted into a strong business performance: Organically, our core business grew by 7% for the full year – at the top end of our guidance range – and ended with very strong growth of 11% in Q4. The EBITDA margin development...

Continue reading

Corbion resultaten boekjaar 2020

Corbion boekte een netto-omzet van € 986,5 miljoen in 2020. De autonome groei van de netto-omzet was 5,6%. De aangepaste EBITDA nam in 2020 autonoom toe met 13,4% tot € 158,8 miljoen. De onderneming stelt voor een regulier dividend in contanten uit te keren ten bedrage van € 0,56 per aandeel.Olivier Rigaud, CEO, licht toe: “2020 was een jaar dat ons nog lang zal heugen. Kort nadat we in maart onze strategie Advance 2025 in maart hadden gepresenteerd, ging de wereld grotendeels op slot en werden onze prioriteiten de gezondheid van onze collega’s, het veiligstellen van onze bevoorrading veiligstellen en ervoor zorgen dat onze klanten nog steeds konden rekenen op tijdige en complete leveringen. Dit resulteerde in een sterke business performance: Onze kernactiviteiten groeiden autonoom met 7%, aan de bovenkant van onze richtbandbreedte, en...

Continue reading

Figures for 2020 – Substantial jump in profitability and a record-high result

Steinhausen, March 5, 2021 – Schweiter Technologies posted a record-high result amid challenging market conditions. Despite the COVID-19 pandemic and negative currency effects, the Group posted sales of CHF 1,160.2 million in 2020, which was only slightly lower than the previous year’s CHF 1,179.6 million (-2%). In local currencies, sales were +3% higher versus 2019. Group EBITDA improved by a staggering +43% compared with the previous year (+49% in local currencies), reaching a new record high of CHF 175.7 million. The return on net sales rose by close to 5 %-points to 15.1%. EBIT also rose faster than sales to CHF 137.6 million (previous year: CHF 85.2 million), while net income increased to CHF 103.5 million (previous year: CHF 60.0 million).Operating cash flow came to about CHF 158 million, equivalent to a year-on-year increase...

Continue reading

Zahlen Jahresabschluss 2020 – Markant höhere Profitabilität und neues Rekordergebnis

Steinhausen, 5. März 2021 – Schweiter Technologies erzielt ein Rekordergebnis in einem anspruchsvollen Marktumfeld. Trotz COVID-19 Pandemie und negativen Währungseinflüssen wurde im 2020 ein Gruppenumsatz erzielt, der mit CHF 1’160.2 Mio. nur leicht unter dem Vorjahreswert von CHF 1‘179.6 Mio. (-2%) liegt. In lokalen Währungen legte der Umsatz gegenüber 2019 um +3% zu. Der EBITDA der Gruppe verbesserte sich im Vergleich zum Vorjahr überproportional um +43% (+49% in lokalen Währungen) auf CHF 175.7 Mio. und erreichte einen neuen Rekordwert. Die Rentabilität zum Nettoumsatz verbesserte sich um knapp 5%-Punkte auf 15.1%. Der EBIT erhöhte sich ebenfalls überproportional auf CHF 137.6 Mio. (Vorjahr: CHF 85.2 Mio.) und der Reingewinn auf CHF 103.5 Mio. (Vorjahr: CHF 60.0 Mio.).Der operative Cashflow belief sich auf rund CHF 158 Mio.,...

Continue reading

Cove Capital Acquires Family Dollar Net Lease Asset in Uniontown, Alabama

LOS ANGELES, March 04, 2021 (GLOBE NEWSWIRE) — Cove Capital Investments, LLC (“Cove Capital”) and its affiliates are pleased to announce the acquisition of the Family Dollar retail store located in Uniontown, Alabama (the “Property”).With approximately 9,180 rentable square feet, the Property is part of a growing portfolio of debt free net-leased properties held in Cove Net Lease Income Fund 18, LLC, a regulation D, Rule 506c private placement, which offers high-net-worth investors the opportunity to easily invest and participate in a diversified* portfolio of net lease properties with long-term leases to high quality tenants. Through acquisition of assets like the Property, Cove Net Lease Income Fund 18 focuses on acquiring, owning, and actively managing income producing net lease industrial, medical and retail properties throughout...

Continue reading

Warburg Pincus Capital Corporation I-B Announces Pricing of $500 Million Initial Public Offering

NEW YORK, March 04, 2021 (GLOBE NEWSWIRE) — Warburg Pincus Capital Corporation I-B (the “Company”) today announced the pricing of 50,000,000 units at $10.00 per unit. The units will be listed on the New York Stock Exchange (the “NYSE”) under the symbol “WPCB.U” commencing on March 5, 2021. Each unit consists of one Class A ordinary share and one-fifth of one redeemable warrant, with each whole warrant entitling the holder thereof to purchase one Class A ordinary share at a price of $11.50 per share. Once the securities constituting the units begin separate trading, we expect that the units will be listed on the NYSE under the symbols “WPCB” and “WPCB WS,” respectively. The initial public offering is expected to close on March 9, 2021, subject to customary closing conditions.Citigroup...

Continue reading

Warburg Pincus Capital Corporation I-A Announces Pricing of $250 Million Initial Public Offering

NEW YORK, March 04, 2021 (GLOBE NEWSWIRE) — Warburg Pincus Capital Corporation I-A (the “Company”) today announced the pricing of 25,000,000 units at $10.00 per unit. The units will be listed on the New York Stock Exchange (the “NYSE”) under the symbol “WPCA.U” commencing on March 5, 2021. Each unit consists of one Class A ordinary share and one-fifth of one redeemable warrant, with each whole warrant entitling the holder thereof to purchase one Class A ordinary share at a price of $11.50 per share. Once the securities constituting the units begin separate trading, we expect that the units will be listed on the NYSE under the symbols “WPCA” and “WPCA WS,” respectively. The initial public offering is expected to close on March 9, 2021, subject to customary closing conditions.Citigroup...

Continue reading

Points International announces upsizing of previously announced bought deal financing to C$27.5 million

NOT FOR DISTRIBUTION TO U.S. NEWSWIRE SERVICES OR FOR RELEASE, PUBLICATION, DISTRIBUTION OR DISSEMINATION DIRECTLY, OR INDIRECTLY, IN WHOLE OR IN PART, IN OR INTO THE UNITED STATESTORONTO, March 04, 2021 (GLOBE NEWSWIRE) — Points International Ltd. (TSX: PTS) (Nasdaq: PCOM) (“Points” or the “Company”), the global leader in powering loyalty commerce, is pleased to announce that it has entered into a revised agreement with a syndicate of underwriters led by Acumen Capital Finance Partners Limited (the “Underwriters”) to increase the size of the previously announced bought deal financing. Pursuant to the amended terms, the Underwriters have agreed to purchase, on a bought deal basis, an aggregate of 1,467,400 common shares of Points (the “Common Shares”) at a price of $18.75 per Common Share (the “Offering Price”) for aggregate gross...

Continue reading

Nurix Therapeutics Announces Pricing of Upsized Public Offering of Common Stock

SAN FRANCISCO, March 04, 2021 (GLOBE NEWSWIRE) — Nurix Therapeutics, Inc. (Nasdaq: NRIX), a biopharmaceutical company developing targeted protein modulation drugs, today announced the pricing of its underwritten public offering of 4,500,000 shares of its common stock at a public offering price of $31.00 per share. The public offering was upsized from the previously announced size of 4,000,000 shares of its common stock. All shares of common stock are being offered by Nurix. The gross proceeds from the offering, before deducting underwriting discounts and commissions and other offering expenses, are expected to be $139.5 million. In addition, Nurix has granted the underwriters a 30-day option to purchase up to an additional 675,000 shares of its common stock at the public offering price, less underwriting discounts and commissions....

Continue reading

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals

Before you continue, please confirm the following:

Professional advisers only

I am a professional adviser and would like to visit the GOLDEA CAPITAL for Professionals website.

Important Notice for Investors:

The services and products offered by Goldalea Capital Ltd. are intended exclusively for professional market participants as defined by applicable laws and regulations. This typically includes institutional investors, qualified investors, and high-net-worth individuals who have sufficient knowledge, experience, resources, and independence to assess the risks of trading on their own.

No Investment Advice:

The information, analyses, and market data provided are for general information purposes only and do not constitute individual investment advice. They should not be construed as a basis for investment decisions and do not take into account the specific investment objectives, financial situation, or individual needs of any recipient.

High Risks:

Trading in financial instruments is associated with significant risks and may result in the complete loss of the invested capital. Goldalea Capital Ltd. accepts no liability for losses incurred as a result of the use of the information provided or the execution of transactions.

Sole Responsibility:

The decision to invest or not to invest is solely the responsibility of the investor. Investors should obtain comprehensive information about the risks involved before making any investment decision and, if necessary, seek independent advice.

No Guarantees:

Goldalea Capital Ltd. makes no warranties or representations as to the accuracy, completeness, or timeliness of the information provided. Markets are subject to constant change, and past performance is not a reliable indicator of future results.

Regional Restrictions:

The services offered by Goldalea Capital Ltd. may not be available to all persons or in all countries. It is the responsibility of the investor to ensure that they are authorized to use the services offered.

Please note: This disclaimer is for general information purposes only and does not replace individual legal or tax advice.